http://streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 16 Jun 2026 07:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/EyePoint+Reports+Inducement+Grants+Under+NASDAQ+Listing+Rule+5635%28c%29%284%29/26650205.html <p align="justify">WATERTOWN, Mass., June 16, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2023 Long-Term Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4).</p> <p align="justify">The Company granted stock options to purchase up to an aggregate of 39,700 shares of EyePoint common stock to three new employees. The stock options were granted on June 15, 2026. The grants were approved http://www.streetinsider.com/Press+Releases/EyePoint+Reports+Inducement+Grants+Under+NASDAQ+Listing+Rule+5635%28c%29%284%29/26650205.html Tue, 16 Jun 2026 07:00:00 -0400 EYPT O.17380644 http://www.streetinsider.com/Press+Releases/EyePoint+Reports+Inducement+Grants+Under+NASDAQ+Listing+Rule+5635%28c%29%284%29/26650205.html <p align="justify">WATERTOWN, Mass., June 16, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2023 Long-Term Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4).</p> <p align="justify">The Company granted stock options to purchase up to an aggregate of 39,700 shares of EyePoint common stock to three new employees. The stock options were granted on June 15, 2026. The grants were approved http://www.streetinsider.com/Press+Releases/EyePoint+Reports+Inducement+Grants+Under+NASDAQ+Listing+Rule+5635%28c%29%284%29/26650205.html Tue, 16 Jun 2026 07:00:00 -0400 EYPT O.17380644 http://www.streetinsider.com/Globe+Newswire/EyePoint+Reports+Inducement+Grants+Under+NASDAQ+Listing+Rule+5635%28c%29%284%29/26650205.html <p align="justify">WATERTOWN, Mass., June 16, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2023 Long-Term Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4).</p> <p align="justify">The Company granted stock options to purchase up to an aggregate of 39,700 shares of EyePoint common stock to three new employees. The stock options were granted on June 15, 2026. The grants were approved http://www.streetinsider.com/Globe+Newswire/EyePoint+Reports+Inducement+Grants+Under+NASDAQ+Listing+Rule+5635%28c%29%284%29/26650205.html Tue, 16 Jun 2026 07:00:00 -0400 EYPT O.17380644 http://www.streetinsider.com/Globe+Newswire/EyePoint+Reports+Inducement+Grants+Under+NASDAQ+Listing+Rule+5635%28c%29%284%29/26650205.html <p align="justify">WATERTOWN, Mass., June 16, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2023 Long-Term Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4).</p> <p align="justify">The Company granted stock options to purchase up to an aggregate of 39,700 shares of EyePoint common stock to three new employees. The stock options were granted on June 15, 2026. The grants were approved http://www.streetinsider.com/Globe+Newswire/EyePoint+Reports+Inducement+Grants+Under+NASDAQ+Listing+Rule+5635%28c%29%284%29/26650205.html Tue, 16 Jun 2026 07:00:00 -0400 EYPT O.17380644 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++EyePoint%2C+Inc.+++++++++++++++++++++++++Filed+by%3A+Commodore+Capital+LP/26599700.html si-local-file:///var/storage/secattach/20260603/26599700.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++EyePoint%2C+Inc.+++++++++++++++++++++++++Filed+by%3A+Commodore+Capital+LP/26599700.html Wed, 03 Jun 2026 16:40:00 -0400 EYPT O.17380644 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++EyePoint%2C+Inc.+++++++++++++++++++++++++Filed+by%3A+Commodore+Capital+LP/26599700.html si-local-file:///var/storage/secattach/20260603/26599700.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++EyePoint%2C+Inc.+++++++++++++++++++++++++Filed+by%3A+Commodore+Capital+LP/26599700.html Wed, 03 Jun 2026 16:40:00 -0400 EYPT O.17380644 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++EyePoint%2C+Inc.++++++++++++For%3A+May+25++Filed+by%3A+Elston+George/26557796.html si-local-file:///var/storage/secattach/20260527/26557796.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++EyePoint%2C+Inc.++++++++++++For%3A+May+25++Filed+by%3A+Elston+George/26557796.html Wed, 27 May 2026 16:06:00 -0400 EYPT O.17380644 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++EyePoint%2C+Inc.++++++++++++For%3A+May+25++Filed+by%3A+Elston+George/26557796.html si-local-file:///var/storage/secattach/20260527/26557796.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++EyePoint%2C+Inc.++++++++++++For%3A+May+25++Filed+by%3A+Elston+George/26557796.html Wed, 27 May 2026 16:06:00 -0400 EYPT O.17380644 http://www.streetinsider.com/Press+Releases/EyePoint+Announces+Participation+at+Upcoming+Investor+Conferences/26517078.html <p>WATERTOWN, Mass., May 19, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced that company management will participate at the following upcoming conferences:</p> <ul type="disc"><li style="margin-bottom:8pt;"><strong>Stifel 2026 Virtual Ophthalmology Forum</strong><br/>Forum: Fireside Chat<br/>Date: May 26, 2026<br/>Time: 9:00 am ET<br/></li></ul> <ul type="disc"><li style="margin-bottom:8pt;"><strong>Jefferies Global Healthcare Conference</strong><br/>Forum: Fireside Chat <br/>Date: June 3, 2026<br/>Time: 4:55 p.m. ET<br/></li><li style="margin-bottom:8pt;"><strong>Goldman Sachs 47</strong><strong>th</strong><strong> Annual Global Healthcare Conference </strong><br/>Forum: Fireside Chat<br/>Date: June 9, 2026<br/>Time: 11:20 a.m. ET</li></ul> <p>A webcast and subsequent archived replay http://www.streetinsider.com/Press+Releases/EyePoint+Announces+Participation+at+Upcoming+Investor+Conferences/26517078.html Tue, 19 May 2026 07:00:00 -0400 A.30352707 EYPT O.13103550 O.17380644 http://www.streetinsider.com/Press+Releases/EyePoint+Announces+Participation+at+Upcoming+Investor+Conferences/26517078.html <p>WATERTOWN, Mass., May 19, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced that company management will participate at the following upcoming conferences:</p> <ul type="disc"><li style="margin-bottom:8pt;"><strong>Stifel 2026 Virtual Ophthalmology Forum</strong><br/>Forum: Fireside Chat<br/>Date: May 26, 2026<br/>Time: 9:00 am ET<br/></li></ul> <ul type="disc"><li style="margin-bottom:8pt;"><strong>Jefferies Global Healthcare Conference</strong><br/>Forum: Fireside Chat <br/>Date: June 3, 2026<br/>Time: 4:55 p.m. ET<br/></li><li style="margin-bottom:8pt;"><strong>Goldman Sachs 47</strong><strong>th</strong><strong> Annual Global Healthcare Conference </strong><br/>Forum: Fireside Chat<br/>Date: June 9, 2026<br/>Time: 11:20 a.m. ET</li></ul> <p>A webcast and subsequent archived replay http://www.streetinsider.com/Press+Releases/EyePoint+Announces+Participation+at+Upcoming+Investor+Conferences/26517078.html Tue, 19 May 2026 07:00:00 -0400 A.30352707 EYPT O.13103550 O.17380644 http://www.streetinsider.com/Press+Releases/EyePoint+Announces+Participation+at+Upcoming+Investor+Conferences/26517078.html <p>WATERTOWN, Mass., May 19, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced that company management will participate at the following upcoming conferences:</p> <ul type="disc"><li style="margin-bottom:8pt;"><strong>Stifel 2026 Virtual Ophthalmology Forum</strong><br/>Forum: Fireside Chat<br/>Date: May 26, 2026<br/>Time: 9:00 am ET<br/></li></ul> <ul type="disc"><li style="margin-bottom:8pt;"><strong>Jefferies Global Healthcare Conference</strong><br/>Forum: Fireside Chat <br/>Date: June 3, 2026<br/>Time: 4:55 p.m. ET<br/></li><li style="margin-bottom:8pt;"><strong>Goldman Sachs 47</strong><strong>th</strong><strong> Annual Global Healthcare Conference </strong><br/>Forum: Fireside Chat<br/>Date: June 9, 2026<br/>Time: 11:20 a.m. ET</li></ul> <p>A webcast and subsequent archived replay http://www.streetinsider.com/Press+Releases/EyePoint+Announces+Participation+at+Upcoming+Investor+Conferences/26517078.html Tue, 19 May 2026 07:00:00 -0400 A.30352707 EYPT O.13103550 O.17380644 http://www.streetinsider.com/Press+Releases/EyePoint+Announces+Participation+at+Upcoming+Investor+Conferences/26517078.html <p>WATERTOWN, Mass., May 19, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced that company management will participate at the following upcoming conferences:</p> <ul type="disc"><li style="margin-bottom:8pt;"><strong>Stifel 2026 Virtual Ophthalmology Forum</strong><br/>Forum: Fireside Chat<br/>Date: May 26, 2026<br/>Time: 9:00 am ET<br/></li></ul> <ul type="disc"><li style="margin-bottom:8pt;"><strong>Jefferies Global Healthcare Conference</strong><br/>Forum: Fireside Chat <br/>Date: June 3, 2026<br/>Time: 4:55 p.m. ET<br/></li><li style="margin-bottom:8pt;"><strong>Goldman Sachs 47</strong><strong>th</strong><strong> Annual Global Healthcare Conference </strong><br/>Forum: Fireside Chat<br/>Date: June 9, 2026<br/>Time: 11:20 a.m. ET</li></ul> <p>A webcast and subsequent archived replay http://www.streetinsider.com/Press+Releases/EyePoint+Announces+Participation+at+Upcoming+Investor+Conferences/26517078.html Tue, 19 May 2026 07:00:00 -0400 A.30352707 EYPT O.13103550 O.17380644 http://www.streetinsider.com/Globe+Newswire/EyePoint+Announces+Participation+at+Upcoming+Investor+Conferences/26517078.html <p>WATERTOWN, Mass., May 19, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced that company management will participate at the following upcoming conferences:</p> <ul type="disc"><li style="margin-bottom:8pt;"><strong>Stifel 2026 Virtual Ophthalmology Forum</strong><br/>Forum: Fireside Chat<br/>Date: May 26, 2026<br/>Time: 9:00 am ET<br/></li></ul> <ul type="disc"><li style="margin-bottom:8pt;"><strong>Jefferies Global Healthcare Conference</strong><br/>Forum: Fireside Chat <br/>Date: June 3, 2026<br/>Time: 4:55 p.m. ET<br/></li><li style="margin-bottom:8pt;"><strong>Goldman Sachs 47</strong><strong>th</strong><strong> Annual Global Healthcare Conference </strong><br/>Forum: Fireside Chat<br/>Date: June 9, 2026<br/>Time: 11:20 a.m. ET</li></ul> <p>A webcast and subsequent archived replay http://www.streetinsider.com/Globe+Newswire/EyePoint+Announces+Participation+at+Upcoming+Investor+Conferences/26517078.html Tue, 19 May 2026 07:00:00 -0400 A.30352707 EYPT O.13103550 O.17380644 http://www.streetinsider.com/Globe+Newswire/EyePoint+Announces+Participation+at+Upcoming+Investor+Conferences/26517078.html <p>WATERTOWN, Mass., May 19, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced that company management will participate at the following upcoming conferences:</p> <ul type="disc"><li style="margin-bottom:8pt;"><strong>Stifel 2026 Virtual Ophthalmology Forum</strong><br/>Forum: Fireside Chat<br/>Date: May 26, 2026<br/>Time: 9:00 am ET<br/></li></ul> <ul type="disc"><li style="margin-bottom:8pt;"><strong>Jefferies Global Healthcare Conference</strong><br/>Forum: Fireside Chat <br/>Date: June 3, 2026<br/>Time: 4:55 p.m. ET<br/></li><li style="margin-bottom:8pt;"><strong>Goldman Sachs 47</strong><strong>th</strong><strong> Annual Global Healthcare Conference </strong><br/>Forum: Fireside Chat<br/>Date: June 9, 2026<br/>Time: 11:20 a.m. ET</li></ul> <p>A webcast and subsequent archived replay http://www.streetinsider.com/Globe+Newswire/EyePoint+Announces+Participation+at+Upcoming+Investor+Conferences/26517078.html Tue, 19 May 2026 07:00:00 -0400 A.30352707 EYPT O.13103550 O.17380644 http://www.streetinsider.com/Globe+Newswire/EyePoint+Announces+Participation+at+Upcoming+Investor+Conferences/26517078.html <p>WATERTOWN, Mass., May 19, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced that company management will participate at the following upcoming conferences:</p> <ul type="disc"><li style="margin-bottom:8pt;"><strong>Stifel 2026 Virtual Ophthalmology Forum</strong><br/>Forum: Fireside Chat<br/>Date: May 26, 2026<br/>Time: 9:00 am ET<br/></li></ul> <ul type="disc"><li style="margin-bottom:8pt;"><strong>Jefferies Global Healthcare Conference</strong><br/>Forum: Fireside Chat <br/>Date: June 3, 2026<br/>Time: 4:55 p.m. ET<br/></li><li style="margin-bottom:8pt;"><strong>Goldman Sachs 47</strong><strong>th</strong><strong> Annual Global Healthcare Conference </strong><br/>Forum: Fireside Chat<br/>Date: June 9, 2026<br/>Time: 11:20 a.m. ET</li></ul> <p>A webcast and subsequent archived replay http://www.streetinsider.com/Globe+Newswire/EyePoint+Announces+Participation+at+Upcoming+Investor+Conferences/26517078.html Tue, 19 May 2026 07:00:00 -0400 A.30352707 EYPT O.13103550 O.17380644 http://www.streetinsider.com/Globe+Newswire/EyePoint+Announces+Participation+at+Upcoming+Investor+Conferences/26517078.html <p>WATERTOWN, Mass., May 19, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced that company management will participate at the following upcoming conferences:</p> <ul type="disc"><li style="margin-bottom:8pt;"><strong>Stifel 2026 Virtual Ophthalmology Forum</strong><br/>Forum: Fireside Chat<br/>Date: May 26, 2026<br/>Time: 9:00 am ET<br/></li></ul> <ul type="disc"><li style="margin-bottom:8pt;"><strong>Jefferies Global Healthcare Conference</strong><br/>Forum: Fireside Chat <br/>Date: June 3, 2026<br/>Time: 4:55 p.m. ET<br/></li><li style="margin-bottom:8pt;"><strong>Goldman Sachs 47</strong><strong>th</strong><strong> Annual Global Healthcare Conference </strong><br/>Forum: Fireside Chat<br/>Date: June 9, 2026<br/>Time: 11:20 a.m. ET</li></ul> <p>A webcast and subsequent archived replay http://www.streetinsider.com/Globe+Newswire/EyePoint+Announces+Participation+at+Upcoming+Investor+Conferences/26517078.html Tue, 19 May 2026 07:00:00 -0400 A.30352707 EYPT O.13103550 O.17380644 http://www.streetinsider.com/Press+Releases/EyePoint+Reports+Inducement+Grants+Under+NASDAQ+Listing+Rule+5635%28c%29%284%29/26509933.html <p align="justify">WATERTOWN, Mass., May 18, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2023 Long-Term Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4).</p> <p align="justify">The Company granted stock options to purchase up to an aggregate of 158,100 shares of EyePoint common stock to eight new employees. The stock options were granted on May 15, 2026. The grants were approved http://www.streetinsider.com/Press+Releases/EyePoint+Reports+Inducement+Grants+Under+NASDAQ+Listing+Rule+5635%28c%29%284%29/26509933.html Mon, 18 May 2026 07:00:00 -0400 A.30352707 EYPT O.13103550 O.17380644 http://www.streetinsider.com/Press+Releases/EyePoint+Reports+Inducement+Grants+Under+NASDAQ+Listing+Rule+5635%28c%29%284%29/26509933.html <p align="justify">WATERTOWN, Mass., May 18, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2023 Long-Term Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4).</p> <p align="justify">The Company granted stock options to purchase up to an aggregate of 158,100 shares of EyePoint common stock to eight new employees. The stock options were granted on May 15, 2026. The grants were approved http://www.streetinsider.com/Press+Releases/EyePoint+Reports+Inducement+Grants+Under+NASDAQ+Listing+Rule+5635%28c%29%284%29/26509933.html Mon, 18 May 2026 07:00:00 -0400 A.30352707 EYPT O.13103550 O.17380644 http://www.streetinsider.com/Press+Releases/EyePoint+Reports+Inducement+Grants+Under+NASDAQ+Listing+Rule+5635%28c%29%284%29/26509933.html <p align="justify">WATERTOWN, Mass., May 18, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2023 Long-Term Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4).</p> <p align="justify">The Company granted stock options to purchase up to an aggregate of 158,100 shares of EyePoint common stock to eight new employees. The stock options were granted on May 15, 2026. The grants were approved http://www.streetinsider.com/Press+Releases/EyePoint+Reports+Inducement+Grants+Under+NASDAQ+Listing+Rule+5635%28c%29%284%29/26509933.html Mon, 18 May 2026 07:00:00 -0400 A.30352707 EYPT O.13103550 O.17380644 http://www.streetinsider.com/Press+Releases/EyePoint+Reports+Inducement+Grants+Under+NASDAQ+Listing+Rule+5635%28c%29%284%29/26509933.html <p align="justify">WATERTOWN, Mass., May 18, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2023 Long-Term Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4).</p> <p align="justify">The Company granted stock options to purchase up to an aggregate of 158,100 shares of EyePoint common stock to eight new employees. The stock options were granted on May 15, 2026. The grants were approved http://www.streetinsider.com/Press+Releases/EyePoint+Reports+Inducement+Grants+Under+NASDAQ+Listing+Rule+5635%28c%29%284%29/26509933.html Mon, 18 May 2026 07:00:00 -0400 A.30352707 EYPT O.13103550 O.17380644 http://www.streetinsider.com/Globe+Newswire/EyePoint+Reports+Inducement+Grants+Under+NASDAQ+Listing+Rule+5635%28c%29%284%29/26509933.html <p align="justify">WATERTOWN, Mass., May 18, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2023 Long-Term Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4).</p> <p align="justify">The Company granted stock options to purchase up to an aggregate of 158,100 shares of EyePoint common stock to eight new employees. The stock options were granted on May 15, 2026. The grants were approved http://www.streetinsider.com/Globe+Newswire/EyePoint+Reports+Inducement+Grants+Under+NASDAQ+Listing+Rule+5635%28c%29%284%29/26509933.html Mon, 18 May 2026 07:00:00 -0400 A.30352707 EYPT O.13103550 O.17380644 http://www.streetinsider.com/Globe+Newswire/EyePoint+Reports+Inducement+Grants+Under+NASDAQ+Listing+Rule+5635%28c%29%284%29/26509933.html <p align="justify">WATERTOWN, Mass., May 18, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2023 Long-Term Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4).</p> <p align="justify">The Company granted stock options to purchase up to an aggregate of 158,100 shares of EyePoint common stock to eight new employees. The stock options were granted on May 15, 2026. The grants were approved http://www.streetinsider.com/Globe+Newswire/EyePoint+Reports+Inducement+Grants+Under+NASDAQ+Listing+Rule+5635%28c%29%284%29/26509933.html Mon, 18 May 2026 07:00:00 -0400 A.30352707 EYPT O.13103550 O.17380644 http://www.streetinsider.com/Globe+Newswire/EyePoint+Reports+Inducement+Grants+Under+NASDAQ+Listing+Rule+5635%28c%29%284%29/26509933.html <p align="justify">WATERTOWN, Mass., May 18, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2023 Long-Term Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4).</p> <p align="justify">The Company granted stock options to purchase up to an aggregate of 158,100 shares of EyePoint common stock to eight new employees. The stock options were granted on May 15, 2026. The grants were approved http://www.streetinsider.com/Globe+Newswire/EyePoint+Reports+Inducement+Grants+Under+NASDAQ+Listing+Rule+5635%28c%29%284%29/26509933.html Mon, 18 May 2026 07:00:00 -0400 A.30352707 EYPT O.13103550 O.17380644 http://www.streetinsider.com/Globe+Newswire/EyePoint+Reports+Inducement+Grants+Under+NASDAQ+Listing+Rule+5635%28c%29%284%29/26509933.html <p align="justify">WATERTOWN, Mass., May 18, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2023 Long-Term Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4).</p> <p align="justify">The Company granted stock options to purchase up to an aggregate of 158,100 shares of EyePoint common stock to eight new employees. The stock options were granted on May 15, 2026. The grants were approved http://www.streetinsider.com/Globe+Newswire/EyePoint+Reports+Inducement+Grants+Under+NASDAQ+Listing+Rule+5635%28c%29%284%29/26509933.html Mon, 18 May 2026 07:00:00 -0400 A.30352707 EYPT O.13103550 O.17380644 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++EyePoint%2C+Inc.+++++++++++++++++++++++++Filed+by%3A+Paradigm+Biocapital+Advisors+LP/26506465.html si-local-file:///var/storage/secattach/20260515/26506465.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++EyePoint%2C+Inc.+++++++++++++++++++++++++Filed+by%3A+Paradigm+Biocapital+Advisors+LP/26506465.html Fri, 15 May 2026 16:33:00 -0400 EYPT O.17380644